Delivery Order SPE2DB20D2001-SPE2DB22FM36L
- Not listed
- This federal contract award, with a ceiling value of $1,077.16, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, Corporate Office Division. The award is for the delivery of ADZENYS XR-ODT 12.5 MG TABLET UD 30S, a pharmaceutical product. The contract has an ultimate completion date of October 11, 2024 and is a firm fixed-price delivery order, with no set-aside designation. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical...
- This federal contract award, valued at $3,937.60, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Adzenys XR-ODT 9.4 mg tablet in 30-unit doses. This contract is a delivery order under a broader Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. The IDC enables...
- This federal contract award, valued at $3,171.39, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order for the supply of ADZENYS XR-ODT 12.5 MG TABLET UD 30S, a prescription medication. This contract is not designated as a set-aside. The award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999, held by AmerisourceBergen with the DLA Troop Support Medical. This IDC...
- This federal contract award is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ADZENYS XR-ODT 9.4 MG TABLET UD 30S, a prescription medication, with a ceiling value of $2,212.51 and a performance period ending on June 27, 2025. The contract is not set-aside and was awarded on a firm-fixed-price basis. AmerisourceBergen Drug Corp holds a...
- This is a $1,642.02 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ADZENYS XR-ODT 3.1 MG TABLET UD 30S, a pharmaceutical product. The contract has an ultimate completion date of January 21, 2025 and was awarded on January 17, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,474.33 firm fixed-price delivery order is for the supply of ADZENYS XR-ODT 12.5 MG TABLET UD 30S, a prescription medication. The contract has an ultimate completion date of April 22, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- The federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of ADZENYS XR-ODT 18.8 MG TABLET UD 30S. The contract has a ceiling value of $1,722.53 and is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA), a defense agency. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award, valued at $2,183.13, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The contract is a delivery order for the pharmaceutical product Adzenys XR ODT Tabs 1's 9.4mg. Amerisourcebergen, a major pharmaceutical distributor and healthcare solutions provider, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
- This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,148.52, is for the delivery of ADZENYS XR-ODT 12.5 MG TABLET UD 30S, a specialty pharmaceutical product. The contract is a Firm Fixed Price arrangement and has an ultimate completion date of February 14, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,321.04 Firm Fixed Price delivery order is for the supply of ADZENYS XR-ODT 12.5 MG TABLET UD 30S, with a completion date of November 22, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- SPE2DB20D2001Indefinite Delivery Contract
- SPE2DB20D2001-SPE2DB22FM36LDelivery Order
This federal contract award, valued at $1,111.53, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide 4555889932 - ADZENYS XR-ODT 15.7 MG TABLET UD 30S. The contract is a Delivery Order under a broader Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical division. This IDC, valued at up to $999,999,999.00, serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions worldwide. The contract does not have a set-aside designation, indicating it was awarded through full and open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 1/10/22 |